Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors

Clinical trial NCT00394446 · COMPLETED

Trial details

NCT number: NCT00394446
Sponsor: Myrexis Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Solid Tumors

Start date: 2005-03-01
Primary completion: 2007-04-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.